Cipla gains on partner's contract win
Reuters Market Eye - Shares in drugmaker Cipla(CIPL.NS) rise 1.4 percent after Cipla Medpro CMPJ.J won a share in South Africa's $667 million contract, as it supplies the bulk of Cipla Medpro's drugs.
Dealers say the company may garner revenues of $30-40 million from Cipla Medpro's contract.
South Africa on Thursday awarded a $667 million contract to supply life-prolonging HIV medicine to 12 international and domestic firms, including Cipla Medpro, to deal with its biggest health problem.
Cipla also plans to offer $215 million for a majority stake in South Africa's Cipla Medpro to strengthen its presence in Africa's fast-growing market for cheap, generic versions of branded drugs.
- Tweet this
- Share this
- Digg this
- US STOCKS-Dow, S&P 500 end at record highs; BoJ move adds fuel to rally
- Judge rejects strict limits on U.S. nurse who treated Ebola patients |
- 'Plastic' Halloween skulls found in Connecticut are human remains
- Judge rejects strict limits on U.S. nurse who treated Ebola patients
- Protests force out Burkina president, soldiers vie for power
Shares Hit Record
The BSE Sensex and Nifty surged to record highs for a second consecutive session on Friday after Bank of Japan's surprise expansion of its massive stimulus programme raised hopes for additional foreign inflows, boosting blue-chips such as Larsen & Toubro. Full Article
China's shadow banking sector growing rapidly, third largest in world - FSB. Full Article